Helsingin Yiopisto, Finland

Katarzyna Leskinen

This inventor holds 1 USPTO granted patent. Top assignee: Arivin Therapeutics Oy. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katarzyna Leskinen. Retrieved from https://idiyas.com/inventor/katarzyna-leskinen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katarzyna Leskinen and Antimicrobial Combination Innovation.

Introduction

Katarzyna Leskinen is a woman inventor associated with Helsingin Yliopisto, Finland, and Arivin Therapeutics Oy. Her patent work focuses on combining a macrocyclic cavity-containing compound with an antimicrobial agent.

Latest Patents

Leskinen is associated with 1 patent, titled “Combinatory treatment.” The invention describes using a macrocyclic cavity-containing compound to sensitize a microbe to an antimicrobial agent. It also addresses reducing the amount of antimicrobial agent needed to prevent or inhibit microbial growth, limiting the development of microbial resistance, and using the compound together with an antimicrobial agent to inhibit, treat, or prevent microbial infection.

Career Highlights

Her patent reflects an approach to antimicrobial treatment that aims to improve an agent’s effectiveness while potentially reducing the amount required. The disclosed uses also address the challenge of microbial resistance.

Collaborations

The provided information names Markus Linder and Ekaterina Osmekhina as Leskinen’s coworkers. Her company affiliation is Arivin Therapeutics Oy.

Conclusion

Katarzyna Leskinen’s patent centers on combining a macrocyclic compound with antimicrobial agents to support infection treatment and address resistance.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…